Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026)

Hims & Hers Health (HIMS) reported Other Non-Current Assets of $47.6 million for Q1 2026, up 2352.37% on a YoY basis from $1.9 million in Q1 2025, and up 60.46% sequentially from $29.7 million in Q4 2025.

Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Other Non-Current Assets data on file, last reported at $47.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 2352.37% year-over-year to $47.6 million; the trailing twelve-month figure through Mar 2026 stood at $47.6 million (up 2352.37% YoY), and the FY2025 full-year result was $29.7 million, up 3367.29% from the prior year.
  • Other Non-Current Assets grew to $47.6 million in Q1 2026, from $29.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $47.6 million in Q1 2026 to a low of $856000.0 in Q1 2022.
  • A 5-year average of $5.6 million and a median of $856000.0 in 2022 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and soared 3367.29% in 2025, its largest moves.
  • Tracing HIMS's Other Non-Current Assets over 5 years: stood at $856000.0 in 2022, then changed by 0.0% to $856000.0 in 2023, then changed by 0.0% to $856000.0 in 2024, then soared by 3367.29% to $29.7 million in 2025, then jumped by 60.46% to $47.6 million in 2026.
  • Business Quant data shows HIMS's Other Non-Current Assets at $47.6 million in Q1 2026, $29.7 million in Q4 2025, and $3.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 377.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 233.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 169,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 295.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 47.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.63 Mn
Dec 31, 2025 29.68 Mn
Sep 30, 2025 3.88 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 1.94 Mn
Dec 31, 2024 856,000.00
Sep 30, 2024 856,000.00
Jun 30, 2024 856,000.00
Mar 31, 2024 856,000.00
Dec 31, 2023 856,000.00
Sep 30, 2023 856,000.00
Jun 30, 2023 856,000.00
Mar 31, 2023 856,000.00
Dec 31, 2022 856,000.00
Sep 30, 2022 856,000.00
Jun 30, 2022 856,000.00
Mar 31, 2022 856,000.00
Dec 31, 2021 856,000.00
Sep 30, 2021 856,000.00
Jun 30, 2021 856,000.00